Logo image of EXPL.PA

EXPLOSIFS PROD. CHI (EXPL.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:EXPL - FR0014003AQ4 - Common Stock

224 EUR
0 (0%)
Last: 12/23/2025, 7:00:00 PM
Fundamental Rating

6

Taking everything into account, EXPL scores 6 out of 10 in our fundamental rating. EXPL was compared to 75 industry peers in the Chemicals industry. EXPL scores excellent on profitability, but there are some minor concerns on its financial health. EXPL has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year EXPL was profitable.
In the past year EXPL had a positive cash flow from operations.
Of the past 5 years EXPL 4 years were profitable.
Each year in the past 5 years EXPL had a positive operating cash flow.
EXPL.PA Yearly Net Income VS EBIT VS OCF VS FCFEXPL.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

1.2 Ratios

Looking at the Return On Assets, with a value of 5.09%, EXPL is in the better half of the industry, outperforming 70.67% of the companies in the same industry.
Looking at the Return On Equity, with a value of 14.45%, EXPL belongs to the top of the industry, outperforming 81.33% of the companies in the same industry.
With a decent Return On Invested Capital value of 6.95%, EXPL is doing good in the industry, outperforming 68.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for EXPL is in line with the industry average of 7.13%.
The 3 year average ROIC (6.05%) for EXPL is below the current ROIC(6.95%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.09%
ROE 14.45%
ROIC 6.95%
ROA(3y)4.57%
ROA(5y)1.96%
ROE(3y)14.45%
ROE(5y)5.2%
ROIC(3y)6.05%
ROIC(5y)5%
EXPL.PA Yearly ROA, ROE, ROICEXPL.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

Looking at the Profit Margin, with a value of 4.92%, EXPL is in the better half of the industry, outperforming 62.67% of the companies in the same industry.
In the last couple of years the Profit Margin of EXPL has grown nicely.
EXPL has a Operating Margin (4.83%) which is comparable to the rest of the industry.
EXPL's Operating Margin has improved in the last couple of years.
EXPL has a Gross Margin of 60.94%. This is amongst the best in the industry. EXPL outperforms 90.67% of its industry peers.
In the last couple of years the Gross Margin of EXPL has grown nicely.
Industry RankSector Rank
OM 4.83%
PM (TTM) 4.92%
GM 60.94%
OM growth 3Y7%
OM growth 5Y14.64%
PM growth 3Y44.63%
PM growth 5YN/A
GM growth 3Y0.5%
GM growth 5Y11.18%
EXPL.PA Yearly Profit, Operating, Gross MarginsEXPL.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), EXPL is destroying value.
Compared to 1 year ago, EXPL has more shares outstanding
Compared to 5 years ago, EXPL has more shares outstanding
The debt/assets ratio for EXPL has been reduced compared to a year ago.
EXPL.PA Yearly Shares OutstandingEXPL.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M
EXPL.PA Yearly Total Debt VS Total AssetsEXPL.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

An Altman-Z score of 2.82 indicates that EXPL is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of EXPL (2.82) is better than 64.00% of its industry peers.
EXPL has a debt to FCF ratio of 4.18. This is a neutral value as EXPL would need 4.18 years to pay back of all of its debts.
EXPL has a better Debt to FCF ratio (4.18) than 85.33% of its industry peers.
EXPL has a Debt/Equity ratio of 0.49. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of EXPL (0.49) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 4.18
Altman-Z 2.82
ROIC/WACC0.91
WACC7.6%
EXPL.PA Yearly LT Debt VS Equity VS FCFEXPL.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

EXPL has a Current Ratio of 1.33. This is a normal value and indicates that EXPL is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of EXPL (1.33) is worse than 76.00% of its industry peers.
EXPL has a Quick Ratio of 1.03. This is a normal value and indicates that EXPL is financially healthy and should not expect problems in meeting its short term obligations.
EXPL has a Quick ratio of 1.03. This is comparable to the rest of the industry: EXPL outperforms 42.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 1.03
EXPL.PA Yearly Current Assets VS Current LiabilitesEXPL.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

5

3. Growth

3.1 Past

EXPL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.16%, which is quite good.
The Earnings Per Share has been growing by 50.59% on average over the past years. This is a very strong growth
Looking at the last year, EXPL shows a small growth in Revenue. The Revenue has grown by 5.49% in the last year.
Measured over the past years, EXPL shows a small growth in Revenue. The Revenue has been growing by 7.27% on average per year.
EPS 1Y (TTM)16.16%
EPS 3Y50.59%
EPS 5YN/A
EPS Q2Q%11.02%
Revenue 1Y (TTM)5.49%
Revenue growth 3Y9.08%
Revenue growth 5Y7.27%
Sales Q2Q%7.52%

3.2 Future

The Earnings Per Share is expected to grow by 14.87% on average over the next years. This is quite good.
Based on estimates for the next years, EXPL will show a small growth in Revenue. The Revenue will grow by 4.90% on average per year.
EPS Next Y1.83%
EPS Next 2Y17.09%
EPS Next 3Y14.87%
EPS Next 5YN/A
Revenue Next Year5.87%
Revenue Next 2Y6.07%
Revenue Next 3Y4.9%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
EXPL.PA Yearly Revenue VS EstimatesEXPL.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
EXPL.PA Yearly EPS VS EstimatesEXPL.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 5 10 15

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 19.05, which indicates a rather expensive current valuation of EXPL.
Based on the Price/Earnings ratio, EXPL is valued a bit cheaper than the industry average as 61.33% of the companies are valued more expensively.
EXPL is valuated rather cheaply when we compare the Price/Earnings ratio to 26.50, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 13.33, the valuation of EXPL can be described as correct.
Based on the Price/Forward Earnings ratio, EXPL is valued a bit cheaper than 68.00% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.93, EXPL is valued a bit cheaper.
Industry RankSector Rank
PE 19.05
Fwd PE 13.33
EXPL.PA Price Earnings VS Forward Price EarningsEXPL.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as EXPL.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of EXPL indicates a somewhat cheap valuation: EXPL is cheaper than 73.33% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 19.05
EV/EBITDA 11.06
EXPL.PA Per share dataEXPL.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates EXPL does not grow enough to justify the current Price/Earnings ratio.
EXPL has an outstanding profitability rating, which may justify a higher PE ratio.
EXPL's earnings are expected to grow with 14.87% in the coming years. This may justify a more expensive valuation.
PEG (NY)10.41
PEG (5Y)N/A
EPS Next 2Y17.09%
EPS Next 3Y14.87%

2

5. Dividend

5.1 Amount

EXPL has a yearly dividend return of 0.66%, which is pretty low.
Compared to an average industry Dividend Yield of 2.58, EXPL is paying slightly less dividend.
With a Dividend Yield of 0.66, EXPL pays less dividend than the S&P500 average, which is at 1.87.
Industry RankSector Rank
Dividend Yield 0.66%

5.2 History

The dividend of EXPL decreases each year by -6.38%.
Dividend Growth(5Y)-6.38%
Div Incr Years1
Div Non Decr Years1
EXPL.PA Yearly Dividends per shareEXPL.PA Yearly Dividends per shareYearly Dividends per share 2019 2024 2025 0.5 1

5.3 Sustainability

8.44% of the earnings are spent on dividend by EXPL. This is a low number and sustainable payout ratio.
DP8.44%
EPS Next 2Y17.09%
EPS Next 3Y14.87%
EXPL.PA Yearly Income VS Free CF VS DividendEXPL.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M 40M
EXPL.PA Dividend Payout.EXPL.PA Dividend Payout, showing the Payout Ratio.EXPL.PA Dividend Payout.PayoutRetained Earnings

EXPLOSIFS PROD. CHI

EPA:EXPL (12/23/2025, 7:00:00 PM)

224

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-13 2025-11-13
Earnings (Next)N/A N/A
Inst Owners3.65%
Inst Owner ChangeN/A
Ins Owners0.42%
Ins Owner ChangeN/A
Market Cap506.24M
Revenue(TTM)508.38M
Net Income(TTM)25.00M
Analysts82.86
Price Target221.34 (-1.19%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.66%
Yearly Dividend1
Dividend Growth(5Y)-6.38%
DP8.44%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-5.19%
EPS NY rev (3m)-14.7%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.74%
Revenue NY rev (3m)2.58%
Valuation
Industry RankSector Rank
PE 19.05
Fwd PE 13.33
P/S 1
P/FCF 19.05
P/OCF 8.95
P/B 2.93
P/tB 3.35
EV/EBITDA 11.06
EPS(TTM)11.76
EY5.25%
EPS(NY)16.81
Fwd EY7.5%
FCF(TTM)11.76
FCFY5.25%
OCF(TTM)25.03
OCFY11.17%
SpS224.95
BVpS76.55
TBVpS66.93
PEG (NY)10.41
PEG (5Y)N/A
Graham Number142.32
Profitability
Industry RankSector Rank
ROA 5.09%
ROE 14.45%
ROCE 8.22%
ROIC 6.95%
ROICexc 6.95%
ROICexgc 7.49%
OM 4.83%
PM (TTM) 4.92%
GM 60.94%
FCFM 5.23%
ROA(3y)4.57%
ROA(5y)1.96%
ROE(3y)14.45%
ROE(5y)5.2%
ROIC(3y)6.05%
ROIC(5y)5%
ROICexc(3y)6.53%
ROICexc(5y)5.46%
ROICexgc(3y)6.95%
ROICexgc(5y)5.82%
ROCE(3y)7.08%
ROCE(5y)5.87%
ROICexgc growth 3Y1.85%
ROICexgc growth 5Y14.27%
ROICexc growth 3Y2.26%
ROICexc growth 5Y15.73%
OM growth 3Y7%
OM growth 5Y14.64%
PM growth 3Y44.63%
PM growth 5YN/A
GM growth 3Y0.5%
GM growth 5Y11.18%
F-Score6
Asset Turnover1.04
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 4.18
Debt/EBITDA 1.5
Cap/Depr 93.75%
Cap/Sales 5.9%
Interest Coverage 4.14
Cash Conversion 99.99%
Profit Quality 106.28%
Current Ratio 1.33
Quick Ratio 1.03
Altman-Z 2.82
F-Score6
WACC7.6%
ROIC/WACC0.91
Cap/Depr(3y)105.53%
Cap/Depr(5y)86.25%
Cap/Sales(3y)5.43%
Cap/Sales(5y)5.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.16%
EPS 3Y50.59%
EPS 5YN/A
EPS Q2Q%11.02%
EPS Next Y1.83%
EPS Next 2Y17.09%
EPS Next 3Y14.87%
EPS Next 5YN/A
Revenue 1Y (TTM)5.49%
Revenue growth 3Y9.08%
Revenue growth 5Y7.27%
Sales Q2Q%7.52%
Revenue Next Year5.87%
Revenue Next 2Y6.07%
Revenue Next 3Y4.9%
Revenue Next 5YN/A
EBIT growth 1Y32.6%
EBIT growth 3Y16.72%
EBIT growth 5Y22.98%
EBIT Next Year71.63%
EBIT Next 3Y30.85%
EBIT Next 5YN/A
FCF growth 1Y362.81%
FCF growth 3Y50.02%
FCF growth 5Y78.21%
OCF growth 1Y403.74%
OCF growth 3Y33.67%
OCF growth 5Y25.42%

EXPLOSIFS PROD. CHI / EXPL.PA FAQ

What is the ChartMill fundamental rating of EXPLOSIFS PROD. CHI (EXPL.PA) stock?

ChartMill assigns a fundamental rating of 6 / 10 to EXPL.PA.


Can you provide the valuation status for EXPLOSIFS PROD. CHI?

ChartMill assigns a valuation rating of 5 / 10 to EXPLOSIFS PROD. CHI (EXPL.PA). This can be considered as Fairly Valued.


Can you provide the profitability details for EXPLOSIFS PROD. CHI?

EXPLOSIFS PROD. CHI (EXPL.PA) has a profitability rating of 8 / 10.


Can you provide the PE and PB ratios for EXPL stock?

The Price/Earnings (PE) ratio for EXPLOSIFS PROD. CHI (EXPL.PA) is 19.05 and the Price/Book (PB) ratio is 2.93.


Can you provide the financial health for EXPL stock?

The financial health rating of EXPLOSIFS PROD. CHI (EXPL.PA) is 5 / 10.